Hook & thesis
Don’t confuse crisis with death. Lululemon has endured a rough stretch: slowing sales, guidance cuts under new leadership and an earnings shock that prompted investigations and a sizable down-leg in early September. That said, the sell-off looks more like a severe pullback than an existential problem. At roughly $99 per share today, the market is valuing the company at about $11.5 billion with an enterprise value under $10 billion, EV/EBITDA near 3.94 and a trailing P/E around 8. That’s not the price of a broken business - it’s the price of a temporarily impaired one.
My trade idea: buy the overshoot and use a measured stop. This is a tactical long aimed at reclaiming lost sentiment and basic operational stabilization. The risk here is real - guidance was cut and revenue trends are weak - but the company still throws off meaningful free cash flow and carries a valuation that already discounts a lot of bad news.
What lululemon does and why the market should care
lululemon athletica Inc. designs, manufactures and sells technical athletic apparel, footwear and accessories via company-operated stores and direct-to-consumer channels. The brand commands strong pricing power and customer loyalty in a premium athleisure niche, which historically translated to high margins and category-leading returns on capital.
The market cares because lululemon is a large, profitable consumer franchise that should trade primarily on earnings durability and growth trajectory. When comps roll over and guidance is cut, multiples compress quickly because the business is scaled: small percentage drops in revenue bite more meaningfully into EBITDA and EPS. That’s the dynamic investors are wrestling with now.
Fundamentals and the current backdrop
Key, concrete data points that matter for valuation and the trade:
- Market capitalization: approximately $11.48 billion.
- Enterprise value: ~$9.93 billion; EV/EBITDA: ~3.94.
- Trailing earnings per share: $12.24, yielding a P/E of ~8 on recent prices.
- Reported free cash flow: ~$1.35 billion.
- 52-week range: high $225.98, low $90.38 (recent low 10/08/2026).
Operationally, the company reported year-over-year weakness in recent periods: revenue and comparable sales have been cited as down (one report notes Q2 revenue down 4% to $2.4B and comps down 9%). Management trimmed full-year guidance, which cascaded into the sharp September sell-off. Meanwhile, activist and legal headlines (a Pomerantz investigation tied to the September results) have amplified volatility.
Valuation framing
At roughly $11.5 billion market cap and EV $9.93 billion, the stock is trading at multiples consistent with a severely down-cycle scenario. EV/EBITDA below 4 and a trailing P/E near 8 suggest investors expect materially lower future cash flows or prolonged margin pressure. But consider the balance: reported free cash flow is still meaningful at ~$1.35 billion; enterprise value is less than 8x free cash flow. Those are not liquidation multiples - they’re recovery multiples for a healthy brand with durable cash generation when things normalize.
Relative to its own history, the current price is an extreme discount to the multi-year highs and to the premium multiples the market previously assigned when growth and margins were expanding. That discount creates a tactical buying opportunity if you believe that the core apparel franchise can stabilize and margins can be at least partly restored within a few quarters.
Technical and sentiment read
Technicals are mixed but improving: the 10- and 20-day SMAs sit near $95.52 and $96.55 respectively, with the stock trading above both and the 9-day EMA at $96.77. RSI sits neutral around 50, and the MACD histogram shows bullish momentum emerging. Short interest has been elevated through September and October, and recent short-volume data show heavy short activity on multiple sessions. That creates asymmetric upside in a squeeze scenario if sentiment inflects.
Trade plan (actionable)
Direction: Long
Entry: Buy at $98.50
Stop loss: $89.00
Target: $135.00
Horizon: long term (180 trading days) - expect this trade to unfold over multiple quarters as comps stabilize and margins begin to recover. The 180-trading-day window gives time for operational changes, seasonality, and sentiment to normalize without being too patient for a tactical idea.
Rationale: Buying at $98.50 places you inside recent consolidation and just above the 52-week low area. A stop at $89 caps the downside near the recent low zone while remaining tight enough to respect the new lower-trend regime. The $135 target is a measured recovery toward a mid-cycle multiple expansion (roughly a move toward low-teens P/E on normalized earnings and partial margin recovery), not a return to peak valuations. This gives a favorable risk-reward while acknowledging the business needs time to show improved metrics.
Catalysts that could drive the trade
- Operational stabilization: evidence of sequential improvement in comparable sales and gross margins over two consecutive quarters.
- Management clarity: tangible, credible cost and inventory actions from the CEO and management team that restore margin visibility.
- Re-rating on valuation: exit of panic positioning and short-covering as the headline cycle calms (short-interest and short-volume patterns make this plausible).
- Positive retail seasonality: stronger-than-expected holiday demand or promotional discipline that protects ASPs and margins.
- Legal resolution or material downgrading of investigative concerns, which would remove headline overhangs.
Risks and counterarguments
Every trade here assumes that the company is not structurally impaired. Below are the main arguments against the thesis plus additional risk items to monitor:
- Macro and discretionary weakness: Continued softness in consumer spending or a deeper slowdown in apparel/athleisure could depress revenue and force deeper markdowns, squeezing margins beyond the market’s current discount.
- Management execution risk: New CEO guidance cuts signal execution challenges. If new initiatives fail to arrest declines, earnings could fall materially below current expectations and justify a lower multiple.
- Legal and disclosure risk: The Pomerantz investigation and heightened regulatory scrutiny can prolong volatility and deter buyers until resolved.
- Inventory and margin pressure: If inventory levels remain elevated and force broad discounting, the free cash flow runway will shrink and valuation multiples could re-rate lower.
- Valuation is not a bottom signal: Cheap multiples can persist if forward growth expectations collapse or structural threats emerge (e.g., intensifying competition, channel disruption).
Counterargument to the long thesis: One could reasonably argue that the market is correctly pricing a structural slowdown for lululemon - that brand momentum has faded and the firm will need to reallocate significant capital to regain growth. If that proves true, multiples above single digits are inappropriate and the stock could grind lower despite the current attractive headline multiples.
Risk management and sizing
This is a medium-risk trade. Given the company’s size and headline volatility, position sizing should reflect the possibility of a drawn-out recovery. Consider size such that a stop at $89 represents a manageable portfolio loss (for many retail traders that means a 1-2% portfolio risk). Re-assess position after the next two quarterly prints or any material management update.
What would change my mind
I would close the thesis and shift to a skeptical stance if any of the following happen: (1) consecutive quarters of accelerating revenue declines and margin erosion, (2) evidence that the brand is losing premium pricing power to competitors, or (3) a material increase in leverage or capital outflow that undermines free cash flow generation. Conversely, improving comps for two consecutive quarters and recovery in FCF would strengthen the bullish case and warrant trimming the stop and potentially raising the target.
Bottom line
This is not a call that lululemon returns to its prior highs. It is a tactical, numbers-driven trade: the company’s market value and enterprise multiples currently embed severe downside assumptions. If you believe the brand can stop the free-fall in sales and protect margins within the next several quarters, buying on headline overshoot with a disciplined stop offers an asymmetric payoff. Enter at $98.50, stop at $89.00, target $135.00, and give the position time to play out over the next 180 trading days.
Key dates and context
09/03/2026 - the company's earnings release triggered a large decline after lower-than-expected revenue and reduced guidance.
October 2026 - headlines and an investor class-action/SEC probe amplified selling pressure and raised trading volatility.